Print Page  |  Contact Us  |  Sign In  |  Join SFT
News & Press: Front Page News

Hydrocodone-containing products becoming Schedule II drugs

Wednesday, October 8, 2014   (0 Comments)
Share |

Hydrocodone-containing products becoming Schedule II drugs

The Drug Enforcement Agency (DEA) has put into place new requirements for hydrocodone-containing products (HCPs). Effective October 6, 2014, all HCPs will become Schedule II drugs. Currently, some HCPs are Schedule II controlled drugs and some fall under Schedule III. HCPs are used in veterinary hospitals to help control coughing in dogs and to manage pain.

For prescribers, a new prescription will be required for all hydrocodone products prescribed after October 5, 2014. No refills will be allowed, similar to other Schedule II drugs. The DEA will allow pharmacies to dispense HCP refills on prescriptions if the prescription was issued prior to October 6, 2014 and the dispensing refill occurs before the expiration date, not to exceed April 8, 2015. All DEA registrants will have to use official DEA Form 222c to order or transfer any hydrocodone products, rather than simple invoices or packing slips. As with all Schedule II – V controlled drugs, dispensing of greater than 14 days’ supply must be reported to the Prescription Drug Monitoring Program.

For more information click here.

Community Search
Sign In


7/22/2020 » 7/25/2020
2020 Therio Conference

Therio News

SFT Mission

The Society for Theriogenology is an organization of veterinarians dedicated to animal reproduction, whose mission is to promote standards of excellence in reproductive medicine, to provide outreach and education to veterinarians, and to foster continual improvements in theriogenology.

Contact Us

Society for Theriogenology
761 Tiger Oak Drive
Pike Road, AL 36064
Office: (334) 395-4666
Email us.
Copyright © 2019. Society for Theriogenology. All Rights Reserved.

Connect with us: